Xuechao Wang

Deep neural networks have shown potential in analyzing digitized hand-drawn signals for early diagnosis of Parkinson's disease. However, the lack of clear interpretability in existing diagnostic methods presents a challenge to clinical trust. In this paper, we propose PointExplainer, an explainable diagnostic strategy to identify hand-drawn regions that drive model diagnosis. Specifically, PointExplainer assigns discrete attribution values to hand-drawn segments, explicitly quantifying their relative contributions to the model's decision. Its key components include: (i) a diagnosis module, which encodes hand-drawn signals into 3D point clouds to represent hand-drawn trajectories, and (ii) an explanation module, which trains an interpretable surrogate model to approximate the local behavior of the black-box diagnostic model. We also introduce consistency measures to further address the issue of faithfulness in explanations. Extensive experiments on two benchmark datasets and a newly constructed dataset show that PointExplainer can provide intuitive explanations with no diagnostic performance degradation. The source code is available at https://github.com/chaoxuewang/PointExplainer.

Subject: In this article, convolutional networks of one, two, and three dimensions are compared with respect to their ability to distinguish between the drawing tests produced by Parkinson's disease patients and healthy control subjects. Motivation: The application of deep learning techniques for the analysis of drawing tests to support the diagnosis of Parkinson's disease has become a growing trend in the area of Artificial Intelligence. Method: The dynamic features of the handwriting signal are embedded in the static test data to generate one-dimensional time series, two-dimensional RGB images and three-dimensional voxelized point clouds, and then one-, two-, and three-dimensional CNN can be used to automatically extract features for effective diagnosis. Novelty: While there are many results that describe the application of two-dimensional convolutional models to the problem, to the best knowledge of the authors, there are no results based on the application of three-dimensional models and very few using one-dimensional models. Main result: The accuracy of the one-, two- and three-dimensional CNN models was 62.50%, 77.78% and 83.34% in the DraWritePD dataset (acquired by the authors) and 73.33%, 80.00% and 86.67% in the PaHaW dataset (well known from the literature), respectively. For these two data sets, the proposed three-dimensional convolutional classification method exhibits the best diagnostic performance.

In recent years, deep learning methods have achieved great success in various fields due to their strong performance in practical applications. In this paper, we present a light-weight neural network for Parkinson's disease diagnostics, in which a series of hand-drawn data are collected to distinguish Parkinson's disease patients from healthy control subjects. The proposed model consists of a convolution neural network (CNN) cascading to long-short-term memory (LSTM) to adapt the characteristics of collected time-series signals. To make full use of their advantages, a multilayered LSTM model is firstly used to enrich features which are then concatenated with raw data and fed into a shallow one-dimensional (1D) CNN model for efficient classification. Experimental results show that the proposed model achieves a high-quality diagnostic result over multiple evaluation metrics with much fewer parameters and operations, outperforming conventional methods such as support vector machine (SVM), random forest (RF), lightgbm (LGB) and CNN-based methods.

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.